Rep. Gilbert Ray Cisneros, Jr. Buys Novanta Inc. (NASDAQ:NOVT) Shares

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Novanta Inc. (NASDAQ:NOVT). In a filing disclosed on June 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Novanta stock on May 18th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of SoftBank Group (OTCMKTS:SFTBF) on 6/2/2026.
• Purchased $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 5/29/2026.
• Sold $1,001 – $15,000 in shares of AutoZone (NYSE:AZO) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Independent Bank (NASDAQ:INDB) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Arcutis Biotherapeutics (NASDAQ:ARQT) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of HealthEquity (NASDAQ:HQY) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Boston Scientific (NYSE:BSX) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Perella Weinberg Partners (NASDAQ:PWP) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Cooper Companies (NASDAQ:COO) on 5/29/2026.
• Purchased $1,001 – $15,000 in shares of Ligand Pharmaceuticals (NASDAQ:LGND) on 5/29/2026.

Novanta Price Performance

NASDAQ:NOVT traded down $6.07 during trading hours on Wednesday, hitting $154.58. The company’s stock had a trading volume of 603,912 shares, compared to its average volume of 479,439. The stock has a fifty day simple moving average of $141.38 and a 200-day simple moving average of $132.09. The company has a market capitalization of $5.50 billion, a P/E ratio of 112.02 and a beta of 1.68. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $171.85.

Novanta (NASDAQ:NOVT) last released its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.03. The business had revenue of $257.71 million for the quarter, compared to analyst estimates of $253.40 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.Novanta’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $0.74 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. On average, analysts anticipate that Novanta Inc. will post 3.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on NOVT shares. Robert W. Baird set a $180.00 price objective on Novanta in a research note on Tuesday. Wall Street Zen lowered Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research note on Friday, April 17th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $180.00.

Institutional Investors Weigh In On Novanta

Institutional investors have recently added to or reduced their stakes in the business. Summit Creek Advisors LLC lifted its stake in Novanta by 47.5% in the fourth quarter. Summit Creek Advisors LLC now owns 73,673 shares of the technology company’s stock valued at $8,766,000 after buying an additional 23,712 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in Novanta by 75.9% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,399,462 shares of the technology company’s stock valued at $155,536,000 after buying an additional 604,055 shares during the period. Envestnet Asset Management Inc. lifted its stake in Novanta by 15.4% in the third quarter. Envestnet Asset Management Inc. now owns 81,691 shares of the technology company’s stock valued at $8,181,000 after buying an additional 10,896 shares during the period. Legal & General Group Plc lifted its stake in Novanta by 7.8% in the fourth quarter. Legal & General Group Plc now owns 207,053 shares of the technology company’s stock valued at $24,637,000 after buying an additional 14,969 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in Novanta by 4.2% in the third quarter. JPMorgan Chase & Co. now owns 753,111 shares of the technology company’s stock valued at $75,424,000 after buying an additional 30,674 shares during the period. 98.35% of the stock is owned by institutional investors.

Insider Activity at Novanta

In other Novanta news, CFO Robert Buckley sold 9,957 shares of the business’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $116.77, for a total value of $1,162,678.89. Following the transaction, the chief financial officer directly owned 96,616 shares of the company’s stock, valued at approximately $11,281,850.32. The trade was a 9.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Matthijs Glastra sold 7,500 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total value of $1,128,225.00. Following the completion of the transaction, the chief executive officer directly owned 42,761 shares in the company, valued at approximately $6,432,537.23. This trade represents a 14.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 23,957 shares of company stock worth $3,136,229. Insiders own 1.20% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.